List view / Grid view

Michael H. Elliott

 

Security considerations for external research

Intellectual Property (IP) is the lifeblood of the pharmaceutical industry.…

20 October 2016 | By

Intellectual Property (IP) is the lifeblood of the pharmaceutical industry. Without it, there would not be much of a business. Growing research and development globalisation, externalisation, the expansion of electronic data management systems and the lack of consistent global IP enforcement is increasing the capacity of external and internal parties…

Informatics In-Depth Focus 2015

In this Informatics In-Depth Focus: Informatics in 2025, Methods for…

3 September 2015 | By

In this Informatics In-Depth Focus: Informatics in 2025, Methods for the detection of drug-drug interactions in text & Computational approaches to mutagenicity assessments of impurities: in silico methods...

Informatics In-Depth Focus 2012

In this Informatics In-Depth Focus: Developing Informatics for the pharmaceutical…

2 September 2012 | By

In this Informatics In-Depth Focus: Developing Informatics for the pharmaceutical industry; Rolling out a biology ELN at UCB Pharma; Ask the Informatics experts; Laboratory Informatics – Out of the fog and into the cloud?